Director/PDMR Shareholding (5562Q)
October 20 2011 - 8:46AM
UK Regulatory
TIDMPEBI
RNS Number : 5562Q
Port Erin Biopharma Investments Ltd
20 October 2011
20 October 2011
Port Erin Biopharma Investments Limited
("Port Erin" or the "Company")
Director's Dealing
Port Erin, the AIM listed company focused on investing in the
biotechnology and biopharmaceutical sectors, announces that the
Company was today notified that Mr Jim Mellon, the Non-executive
Chairman of Port Erin, today acquired 70,000 ordinary shares of
0.0001 pence each ("Ordinary Shares") at a price of 8.25 pence per
Ordinary Share. Accordingly, Mr Mellon is now interested, in
aggregate, in 3,410,000 Ordinary Shares representing approximately
10.33 per cent. of the Company's issued share capital.
Enquiries:
Libertas Capital Corporate Finance Limited
Sandy Jamieson 0207 569 9650
Rivington Street Corporate Finance Limited
Dru Edmonstone/ Jon Levinson 0207 562 3389
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLBLFLFBFZFBQ
Agronomics (LSE:ANIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agronomics (LSE:ANIC)
Historical Stock Chart
From Jul 2023 to Jul 2024
